Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Drug discovery company Recursion Pharmaceuticals raises $60mm in Series B financing

Executive Summary

Recursion Pharmaceuticals LLC (drug discovery) raised $60mm in its Series B financing round led by Data Collective (also adds a board seat), with participation from all prior institutional investors such as Series A lead Lux Capital, Obvious Ventures, Advantage Capital, Felicis, Epic, and AME, and new investors Mubadala, Menlo Ventures, CRV, Two Sigma, and High-Value Angel Investors.
Deal Industry
  • Digital Health
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies